HPV Prevention and Control Board created a survey about how COVID-19 has affected the cervical screening The COVID-19 pandemic has brought about multiple complex challenges in 2020 including the provision of laboratory services required to support cervical cancer screening programmes.The HPV Prevention and Control Board decided to create a short survey, led by Mario Poljak and Kate Cuschieri, to collect contemporary data on the experience of laboratories on how COVID-19 has affected the ability to deliver “routine” services required to support cervical cancer screening.The Aims of the Survey: The survey is intended for heads of laboratories and/or laboratory managers; in this way, we would hope to capture a single response per laboratory.The survey will help to both quantify the impact and identify common challenges across laboratories, both existing and anticipated. HPV Prevention and Control BoardSurvey: challenges of laboratory services required to support cervical cancer screening programmes Publication date 12 Jul, 2022